LAVA Medtech Acquisition Corp. Warrants
LVACW
LVACW was delisted on the 12th of May, 2023.
33 hedge funds and large institutions have $867K invested in LAVA Medtech Acquisition Corp. Warrants in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
6% more funds holding
Funds holding: 31 → 33 (+2)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
25% less capital invested
Capital invested by funds: $1.15M → $867K (-$283K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
+$14.8K |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$7.01K |
| 3 |
SG
StoneX Group
New York
|
+$3.82K |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
+$3.19K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$8K |
| 2 |
EFI
EHP Funds Inc
Toronto,
Canada
|
-$3.42K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$3K |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$1K |
| 5 |
AGM
Alpine Global Management
New York
|
-$271 |
LVACW Hedge Fund Activity: Q4 2022 in Review
33 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q4 2022, worth a combined $867K — down 25% from $1.15M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new LVACW positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Castle Creek Arbitrage, opening a new position worth an estimated $14.8K. The largest seller was Basso Capital Management, exiting entirely with an estimated $8K sold.
- 33 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q4 2022, up from 31 in Q3 2022.
- Funds reported $867K of LAVA Medtech Acquisition Corp. Warrants stock for Q4 2022, down 25% quarter-over-quarter.
- 5 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q4 2022 and 3 closed out, a net change of +2 holders.
- The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q4 2022 was Castle Creek Arbitrage, an estimated $14.8K added.
- The largest LAVA Medtech Acquisition Corp. Warrants seller in Q4 2022 was Basso Capital Management, an estimated $8K sold.
Based on aggregated 13F filings for Q4 2022.